Bariatric surgery in patients with non-alcoholic fatty liver disease from pathophysiology to clinical effects
Open Access
- 27 February 2019
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 11 (2), 138-149
- https://doi.org/10.4254/wjh.v11.i2.138
Abstract
Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a significant liver disease, and it covers the disease spectrum from simple steatosis with a risk of development of non-alcoholic steatohepatitis (NASH) to fibrosis, subsequent cirrhosis, end-stage liver failure, and liver cancer with a potential need for liver transplantation. NAFLD and NASH are closely related to obesity, metabolic syndrome, and type 2 diabetes (T2D). The role of gut hormones, especially glucagon-like peptide 1 (GLP-1), is important in NAFLD. Bariatric surgery has the potential for inducing great weight loss and may improve the symptoms of metabolic syndrome and T2D. Recent data demonstrated significant effects of bariatric surgery on GLP-1 and other gut hormones and important lipid metabolic and inflammatory abnormalities in the pathophysiology of NAFLD. Therefore, bariatric surgery may reverse the pathological liver changes in NAFLD and NASH patients. In the present review, we describe NAFLD and NASH pathophysiology and the primary effects of bariatric surgery on metabolic pathways. We performed a systematic review of the beneficial and harmful effects and focused on changes in liver disease severity in NAFLD and NASH patients. The specific focus was liver histopathology as assessed by the invasive liver biopsy. Additionally, we reviewed several non-invasive methods used for the assessment of liver disease severity following bariatric surgery.Keywords
This publication has 105 references indexed in Scilit:
- Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver diseaseGut, 2012
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 DiabetesThe New England Journal of Medicine, 2012
- Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric bandingInternational Journal of Obesity, 2011
- Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypassInternational Journal of Obesity, 2011
- Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitisLiver International, 2011
- Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoterHepatology, 2010
- GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in miceJCI Insight, 2009
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceJCI Insight, 2008
- Effect of liver fat on insulin clearanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2007